The RNA sequencing of HNSCC (n = 84) revealed that non-integrated cases had stronger immune signatures, characterized by heightened signatures for CD4+ T-cells, CD8+ T-cells, CD3+ T-cells, NK cells, regulatory T-cells, B cells, NK T-cells, and CD34+ cells. This evidence concerns the gene CD4 and head and neck squamous cell carcinoma.